Ning Liao

1.4k total citations
48 papers, 449 citations indexed

About

Ning Liao is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ning Liao has authored 48 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 26 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Ning Liao's work include Cancer Genomics and Diagnostics (12 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (6 papers). Ning Liao is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Breast Cancer Treatment Studies (10 papers) and HER2/EGFR in Cancer Research (6 papers). Ning Liao collaborates with scholars based in China, United States and Hong Kong. Ning Liao's co-authors include Jianguo Lai, Bo Chen, Guochun Zhang, Xuerui Li, Hsiaopei Mok, Chongyang Ren, Lingzhu Wen, Rong Chen, Cheukfai Li and Danian Dai and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Ning Liao

45 papers receiving 445 citations

Peers

Countries citing papers authored by Ning Liao

Since Specialization

Citations

This map shows the geographic impact of Ning Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Liao more than expected).

Fields of papers citing papers by Ning Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Liao. The network helps show where Ning Liao may publish in the future.

Co-authorship network of co-authors of Ning Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Liao. A scholar is included among the top collaborators of Ning Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Liao. Ning Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neuropeptide TIP39 as a pluripotent brain molecule and its potential functions in postpartum depression 2026 ·Frontiers in Endocrinology ·(unknown), (unknown), (unknown), Ning Liao, (unknown), Zhengzhong Yang, (unknown), (unknown)	0
2	Genistein alleviates rheumatoid arthritis by inhibiting fibroblast-like synovial exosome secretion regulated by the Rab27/nSMase2/Mfge8 pathway 2025 ·Food & Function ·Jiajia Liu, (unknown), (unknown), Ziyan Liu, (unknown), Yuli Song, Xudong Tang, Junwen Fan, Hongyue Xu, (unknown), (unknown), (unknown), Ning Liao, Danping Peng, Yang Wang, Lu Yu	4
3	Prognosis of pediatric BCP‐ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG‐2016 study 2024 ·European Journal Of Haematology ·(unknown), Ning Liao, Xinyu Li, Lihua Yang, Yunyan He, Yan‐Lai Tang, Wuqing Wan, (unknown), (unknown), Qian Kong, (unknown), Lan Xiang, (unknown), (unknown), (unknown), Chuan Wen, Chi Kong Li, (unknown)	0
4	Immune checkpoint inhibitors-related endocrinopathies exhibit increased severity in breast cancer patients: a real-world study 2024 ·Endocrine ·(unknown), Cheukfai Li, Shuting Zhang, Ning Liao, (unknown)	0
5	Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study) 2023 ·European Journal of Cancer ·Jiayu Wang, Li Cai, Yanqiu Song, Tong Sun, Zhongsheng Tong, Yuee Teng, Huiping Li, Quchang Ouyang, Qianjun Chen, Shude Cui, Yongmei Yin, Ning Liao, Qiang Sun, Jifeng Feng, Xiaojia Wang, Binghe Xu	7
6	Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node 2022 ·Breast Cancer ·Ning Liao, Cheukfai Li, Li Cao, Yanhua Chen, Chongyang Ren, Xiaohong Chen, Hsiaopei Mok, Lingzhu Wen, Kai Li, Yulei Wang, Yuchen Zhang, Yingzi Li, (unknown), (unknown), Yuting Luo, Hongrui Li, Wendy Wu, Charles M. Balch, Armando E. Giuliano	3
7	Characteristics of MYC Amplification and Their Association with Clinicopathological and Molecular Factors in Patients with Breast Cancer 2022 ·DNA and Cell Biology ·Li Cao, Chongyang Ren, Guochun Zhang, Xuerui Li, Bo Chen, Kai Li, Cheukfai Li, Hsiaopei Mok, Yulei Wang, Lingzhu Wen, Minghan Jia, Guangnan Wei, Jiali Lin, Ning Liao	5
8	Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo 2022 ·Cell Communication and Signaling ·Yuchen Zhang, Cheukfai Li, Chenglai Xia, (unknown), Zhixing Guo, Chongyang Ren, (unknown), Fang Wang, Liwu Fu, Ning Liao	24
9	Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer 2021 ·Frontiers in Oncology ·Weikai Xiao, Guochun Zhang, Bo Chen, Xiaohong Chen, Lingzhu Wen, Jianguo Lai, Xuerui Li, Min Li, Hao Liu, Jing Liu, Han Han‐Zhang, Analyn Lizaso, Ning Liao	18
10	PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing 2021 ·Breast Cancer ·Minghan Jia, Ning Liao, Bo Chen, Guochun Zhang, Yulei Wang, Xuerui Li, Li Cao, Hsiaopei Mok, Chongyang Ren, Kai Li, Cheukfai Li, Lingzhu Wen, Jiali Lin, Guangnan Wei, Charles M. Balch	8
11	Characterization of AKT Somatic Mutations in Chinese Breast Cancer Patients 2021 ·Cancer Management and Research ·Lingzhu Wen, Guochun Zhang, Chongyang Ren, Xuerui Li, Hsiaopei Mok, Minghan Jia, Yulei Wang, Bo Chen, Kai Li, Li Cao, Cheukfai Li, Weikai Xiao, Jianguo Lai, Jiali Lin, Guangnan Wei, Yingzi Li, Yuchen Zhang, Xiaohong Chen, Ning Liao	5
12	235P Efficacy and safety of first-line therapy with fulvestrant or exemestane for postmenopausal ER+/HER2- advanced breast cancer patients after adjuvant nonsteroidal aromatase inhibitor treatment: A randomized, open-label, multicenter study 2021 ·Annals of Oncology ·(unknown), (unknown), Lei Cai, (unknown), (unknown), Tie Sun, Y K Onno Teng, (unknown), (unknown), Quchang Ouyang, (unknown), Mingjin Yan, (unknown), Yongkai Yin, (unknown), Ning Liao, (unknown), (unknown)	1
13	Leveraging Fitness Tracker and Personalized Exercise Prescription to Promote Breast Cancer Survivors’ Health Outcomes: A Feasibility Study 2020 ·Journal of Clinical Medicine ·Nan Zeng, Ning Liao, (unknown), Wenxi Liu, Zan Gao	6
14	Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes 2019 ·Cancer Medicine ·Jiayu Wang, (unknown), Yujian Shi, (unknown), Tao Sun, Lili Tang, Qing Lü, (unknown), Ning Liao, Feng Jin, (unknown), Tao Huang, Jun Qian, Danmei Pang, Shusen Wang, (unknown), Xinhong Wu, Ying Lin, Haiyan Qin, Binghe Xu	17
15	Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol 2019 ·BMJ Open ·Lun Li, Benlong Yang, Hongyuan Li, Jian Yin, Feng Jin, Siyuan Han, Ning Liao, Jingping Shi, Rui Ling, Zan Li, Lizhi Ouyang, Xiang Wang, Peifen Fu, (unknown), (unknown), (unknown), Haibo Wang, Jian Liu, Zhimin Shao, Jiong Wu	9
16	HER2-positive breast cancer, how far away from the cure?—on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients 2016 ·Chinese Clinical Oncology ·Ning Liao	10
17	GeneSearch™ BLN Assay could replace frozen section and touch imprint cytology for intra-operative assessment of breast sentinel lymph nodes 2013 ·Breast Cancer ·Yongsheng Wang, Yan Hui Liu, Tao Ouyang, (unknown), Jiong Wu, (unknown), Xiao Sun, (unknown), Ning Liao, (unknown)	4
18	Comparative study of one‐step nucleic acid amplification assay, frozen section, and touch imprint cytology for intraoperative assessment of breast sentinel lymph node in Chinese patients 2012 ·Cancer Science ·Yongsheng Wang, Tao Ouyang, Jiong Wu, Yanhui Liu, Xuchen Cao, Xiao Sun, Li Fu, Ning Liao, Wentao Yang, (unknown), (unknown)	26
19	NCCN Breast Cancer Practice Guidelines 2005 ·Journal of Evidence-Based Medicine ·Ning Liao	6
20	RADIOACTIVITY AND ABSOLUTE AGE OF THE YOUNG VOLCANIC ROCKS. 1967 ·PubMed ·Minghua Yang, (unknown), (unknown), Yulei He, Ning Liao	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact